Science translational medicine

Harnessing regulatory T cells to establish immune tolerance.

Science translational medicine

Ho P, Cahir-McFarland E, Fontenot JD, Lodie T, Nada A, Tang Q, Turka LA, Bluestone JA

Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies.

Science translational medicine

Goodman DB, Azimi CS, Kearns K, Talbot A, Garakani K, Garcia J, Patel N, Hwang B, Lee D, Park E, Vykunta VS, Shy BR, Ye CJ, Eyquem J, Marson A, Bluestone JA, Roybal KT

Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Science translational medicine

Bluestone JA, Buckner JH, Fitch M, Gitelman SE, Gupta S, Hellerstein MK, Herold KC, Lares A, Lee MR, Li K, Liu W, Long SA, Masiello LM, Nguyen V, Putnam AL, Rieck M, Sayre PH, Tang Q

Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Science translational medicine

Bluestone JA, Buckner JH, Fitch M, Gitelman SE, Gupta S, Hellerstein MK, Herold KC, Lares A, Lee MR, Li K, Liu W, Long SA, Masiello LM, Nguyen V, Putnam AL, Rieck M, Sayre PH, Tang Q

Immunotherapy: making the case for precision medicine.

Science translational medicine

Bluestone JA, Tang Q

Immunotherapy: making the case for precision medicine.

Science translational medicine

Bluestone JA, Tang Q

Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.

Science translational medicine

Villalta SA, Rosenthal W, Martinez L, Kaur A, Sparwasser T, Tidball JG, Margeta M, Spencer MJ, Bluestone JA

Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.

Science translational medicine

Villalta SA, Rosenthal W, Martinez L, Kaur A, Sparwasser T, Tidball JG, Margeta M, Spencer MJ, Bluestone JA

Cell-based therapeutics: the next pillar of medicine.

Science translational medicine

Fischbach MA, Bluestone JA, Lim WA

Cell-based therapeutics: the next pillar of medicine.

Science translational medicine

Fischbach MA, Bluestone JA, Lim WA

Pages